Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
76°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
495.89
+2.54 (+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
46
47
Next >
3 Stocks That Could Trounce the Market in 2024
February 10, 2024
These stocks appear to have what it takes to beat the market this year.
Via
The Motley Fool
Could Vertex Pharmaceuticals Reach $500 in 2024?
February 10, 2024
Vertex shares have several catalysts on the horizon...
Via
The Motley Fool
3 Growth Stocks With More Potential Than Any Cryptocurrency
February 09, 2024
The stock market is full of opportunities for investors of all risk appetites and trading styles.
Via
The Motley Fool
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
February 09, 2024
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.
Via
InvestorPlace
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review
February 08, 2024
The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Vertex Pharmaceuticals Stock Is Approaching a Huge Catalyst, But Is It a Buy?
February 08, 2024
Its pain medicine isn't precisely what it hoped for, but it could still sell.
Via
The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
February 07, 2024
Via
Benzinga
Vertex's Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs
February 06, 2024
Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits.
Via
Benzinga
Vertex Pharmaceuticals' Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients
February 06, 2024
Vertex Pharmaceuticals' vanza triple program for cystic fibrosis, with superior results in lung function, sweat chloride reduction, and safety.
Via
Benzinga
Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Here's How You Can Invest
February 06, 2024
Its foray into developing analgesics seems to be going swimmingly.
Via
The Motley Fool
Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 06, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
This High-Flying Stock Just Got Some Bad News: Should You Sell?
February 06, 2024
It's just a minor setback for this leading biotech.
Via
The Motley Fool
Vertex's Next-Gen Cystic Fibrosis Drug Scores Big; Shares Rise On Quarterly Beat
February 05, 2024
The company also topped fourth-quarter expectations.
Via
Investor's Business Daily
Earnings Preview: Vertex Pharmaceuticals
February 02, 2024
Via
Benzinga
Key Takeaways From Vertex Pharmaceuticals Analyst Ratings
January 31, 2024
Via
Benzinga
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
February 06, 2024
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements.
Via
InvestorPlace
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
February 05, 2024
VRTX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
February 05, 2024
Wall Street ends week on negative note as traders revise down expectations on Fed rate cuts. Strong economic data and Fed officials' comments push stocks into red, reducing rate cut expectations for...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Vertex Pharmaceuticals Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
February 05, 2024
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 5, 2024.
Via
Benzinga
Will Jerome Powell Spoil Wall Street's Party? US Stock Futures Slip As Fed Chief Maintains Hawkish Tone Ahead Of More Earnings
February 05, 2024
As the market pushes higher despite the Federal Reserve's non-committal stance, traders fear a potential drawdown.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Scheduled For February 5, 2024
February 05, 2024
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million.
Via
Benzinga
Investor Optimism Improves Following Tech Earnings, Jobs Data; S&P 500 Gains For 4th Week
February 05, 2024
The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the "Greed" zone on Friday. U.S. stocks closed higher on Friday, with the S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 3
February 03, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 29 through Feb. 2.
Via
Talk Markets
Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?
February 02, 2024
Vertex shares recently reached an all-time high.
Via
The Motley Fool
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
February 02, 2024
The Dow led the major indexes higher. Big techs diverged on results.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Should Quality Investors Include NASDAQ:VRTX in Their Portfolio?
February 02, 2024
In this article we'll explore the quality characteristics of VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)
Via
Chartmill
Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements
February 01, 2024
Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio.
Via
InvestorPlace
Biotech And Medtech Portfolio Notes On A Fed Day
January 31, 2024
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Buy Alert: 3 Stocks Sitting in the Sweet Spot
January 31, 2024
They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting.
Via
InvestorPlace
Why Vertex Pharmaceuticals Stock Topped the Market Today
January 30, 2024
The company reported that it met its primary endpoint in a study for its non-opioid pain drug.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.